-
Expiry date of Covishield extended to nine months
New Delhi: India’s drug regulator DCGI has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine mont
-
Centre allays concerns on Covishield; says both COVID-19 vaccines effective against UK and Brazilian variants
ICMR Director General Dr Balram Bhargava said that both Covishield and Covaxin are effective against the UK and the Brazilian variants
-
Serum Institute of India seeks Centre’s nod to supply 50 lakh Covishield doses to UK
Serum Institute of India assured the Centre that its own anti-coronavirus vaccination programme will not be disturbed because of this supply
-
Centre revises interval between two doses of Covishield vaccine
The Centre revised the time window within which the 2nd dose of Covishield vaccine can be taken, asking states to administer it between 4-8 weeks ins
-
No signal of concern regarding use of Covishield vaccine in India: Government
With thrombotic events in people who received the vaccine have come to light and as a result, about 10 European countries have paused their AstraZenec
-
Govt places new purchase order with SII for 10 crore doses of Covishield vaccine
The cost of the 10 crore doses of the Oxford-AstraZeneca COVID-19 vaccine, Covishield, would be borne by the health ministry under the budgetary alloc
-
Vaccine conundrum: Should India be worried?
Professor NK Ganguly, former Director General of the Indian Council of Medical Research, believes that India does not have anything to fear
-
South Africa variant of coronavirus not found in India till now, says government
The South African strain spreads more rapidly
